MARINUS PHARMACEUTICALS, INC. Retained Earnings
MARINUS PHARMACEUTICALS, INC. had Retained Earnings of -$670.65 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-11-12
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$670.65M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$646.42M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$610.60M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$571.93M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2024-09-30 | -$670.65M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$646.42M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$610.60M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | -$571.93M 10-Q · filed 2024-11-12 | |
| 2023-09-30 | -$530.16M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | -$497.19M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$465.25M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$430.52M 10-K · filed 2024-03-05 | |
| 2022-09-30 | -$396.21M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | -$469.50M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$430.07M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$410.70M 10-K · filed 2023-03-09 | |
| 2021-09-30 | -$382.40M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$362.89M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | -$339.07M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$311.93M 10-K · filed 2022-03-24 | |
| 2020-09-30 | -$294.46M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$278.80M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$263.13M 10-Q · filed 2020-05-04 | |
| 2019-12-31 | -$235.57M 10-K · filed 2021-03-09 | |
| 2019-09-30 | -$220.16M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | -$206.36M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$193.94M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | -$181.45M 10-K · filed 2020-03-16 | |
| 2018-09-30 | -$171.34M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | -$160.23M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | -$150.73M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | -$144.73M 10-K · filed 2019-03-12 | |
| 2017-09-30 | -$139.99M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | -$135.82M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | -$131.27M 10-Q · filed 2017-05-01 | |
| 2016-12-31 | -$125.83M 10-K · filed 2018-03-07 | |
| 2016-09-30 | -$119.81M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | -$113.35M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$104.40M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | -$97.19M 10-K · filed 2017-03-13 | |
| 2015-09-30 | -$89.57M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | -$84.61M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | -$79.34M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | -$72.34M 10-K · filed 2016-03-07 | |
| 2014-09-30 | -$68.73M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$67.06M 10-Q · filed 2014-10-10 | |
| 2013-12-31 | -$61.50M 10-K · filed 2015-03-12 | -$61.50M 10-Q · filed 2014-10-10 |